952 related articles for article (PubMed ID: 19251712)
1. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
2. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Bryant SC; Sandborn WJ; Smyrk TC
Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
[TBL] [Abstract][Full Text] [Related]
4. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of HLA-DRB1 gene shows no strong association with ulcerative colitis in Chinese patients.
Lü M; Xia B
Int J Immunogenet; 2006 Feb; 33(1):37-40. PubMed ID: 16426241
[TBL] [Abstract][Full Text] [Related]
7. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis.
Masuda H; Nakamura Y; Tanaka T; Hayakawa S
Am J Gastroenterol; 1994 Nov; 89(11):1957-62. PubMed ID: 7942717
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study.
Myung SJ; Yang SK; Jung HY; Chang HS; Park B; Hong WS; Kim JH; Min I
Int J Colorectal Dis; 2002 Jul; 17(4):233-7. PubMed ID: 12073071
[TBL] [Abstract][Full Text] [Related]
10. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population.
Törn C; Gupta M; Sanjeevi CB; Aberg A; Frid A; Landin-Olsson M
Hum Immunol; 2004 Dec; 65(12):1443-50. PubMed ID: 15603871
[TBL] [Abstract][Full Text] [Related]
11. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
[TBL] [Abstract][Full Text] [Related]
12. HLA-B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis.
Aizawa H; Kinouchi Y; Negoro K; Nomura E; Imai G; Takahashi S; Takagi S; Kakuta Y; Tosa M; Mochida A; Matsumura Y; Endo K; Shimosegawa T
Tissue Antigens; 2009 Jun; 73(6):569-74. PubMed ID: 19493234
[TBL] [Abstract][Full Text] [Related]
13. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7.
Aron Y; Desmazes-Dufeu N; Matran R; Polla BS; Dusser D; Lockhart A; Swierczewski E
Clin Exp Allergy; 1996 Jul; 26(7):821-8. PubMed ID: 8842557
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis.
Matsumura Y; Kinouchi Y; Nomura E; Negoro K; Kakuta Y; Endo K; Aizawa H; Takagi S; Takahashi S; Shimosegawa T
Tissue Antigens; 2008 May; 71(5):447-52. PubMed ID: 18416774
[TBL] [Abstract][Full Text] [Related]
16. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
17. HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.
Stanevicha V; Eglite J; Zavadska D; Sochnevs A; Shantere R; Gardovska D
Arthritis Res Ther; 2007; 9(3):R58. PubMed ID: 17559688
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
Mumtaz M; Löfgren S; Hugander A; Dimberg J
Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
[TBL] [Abstract][Full Text] [Related]
20. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
